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SuMMAry Nerve sheath myxoma (NSM) of the oral mucosa is a 
slow-growing, benign, often asymptomatic submucosal mass. We 
report on a case of classical NSM of the tongue, with diagnostic and 
therapeutic approach to the case.
Many NSM arise within the endoneurium of a peripheral nerve. It is 
a rare condition with no apparent differences between sexes in its 
prealence. It can occur at any age.
Key wordS: benign neoplasm, neurothekeoma, male, oral myxo-
mas, oral pathology, peripheral nervous system.
INTroduCTIoN
Nerve sheath myxoma (NSM) of the oral mucosa is 
a slow-growing, benign, often asymptomatic submu-
cosal mass. Many NSM arise within the endoneurium 
of a peripheral nerve (1). It is a rare condition with  no 
apparent differences between sexes in its prevalence. 
It can occur at any age (2). In this report, we describe 
a case of classical NSM of the tongue.  
CASe reporT
In August 2011, a 69-year-old male came to our oral 
pathology department with a painless nodular tongue 
lesion, without antecedent trauma. He reported that the 
tongue lesion had appeared approximately 8 months 
earlier. His chief complaint was speech impediment, pain 
on mastication, and difficulty swallowing. He had hyper-
tension. He did not smoke cigarettes or drink alcohol. 
Intraoral examination revealed a sessile nodule 
on the anterior one-third of the tongue, sized 1.0×0.8 
cm. The surface was smooth and slightly whitish in 
appearance Figure 1). An excisional biopsy of the le-
sion was performed using a diode laser (Figures 2, 3). 
Histopathological examination showed a multi-
lobular cellular growth included in the muscular tis-
sue of the tongue with acanthosis of the squamous 
epithelium. The mucosal connective tissue was com-
posed of myxoid stroma containing round and spin-
dle cells (Figure 4). The tissue specimen was examined 
for tumor markers by immunohistochemical analy-
sis. The immunophenotype of the tumour cells was 
positive for S-100 protein and vimentin, suggesting 
Schwann cell origin (3). (Figures 5, 6, 7) The lesional 
tissue was negative for CD34 antigen expression and 
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epithelial membrane antigen (EMA) antibodies. Im-
munostaining for the proliferation the Ki-67 antigen 
was at 2-3%. The lesion was diagnosed as a classical 
nerve sheath myxoma (NSM). At 8 months of follow-
up there was no evidence of recurrence. 
dISCuSSIoN
Nerve sheath myxoma (NSM) is a benign neoplasm 
of the peripheral nervous system, usually found in the 
dermal and subcutaneous tissues of head, neck, and 
limbs (2,3-6). Harkin and Reed were the first to define 
the disease nerve sheath myxoma in 1969 (1).  Sub-
sequently, in 1980, Gallager and Helwing named the 
lesion neurothekeoma (NTK) (2). The nerve sheath 
derivation of NSM is still debated because the immu-
nohistochemical profile of the three variants has not 
been established.  We are aware of only 41 case re-
ports of NSM of the oral mucosa published between 
1974 to 2013 (7) and retrievable through PubMed’s 
Medline. (Table 1). Locations of NSM in the oral cav-
ity were: tongue (n=11), buccal mucosae (n=7), lips 
(n=6), palate (n=1), retromolar area (n=1), gingiva 
(n=1). Epidemiological data indicates a wide range of 
age from 1 to 73 years (mean age 32.7 years), and a 
female/male ratio of 1.4:1 (4).
The current classification of NSM is based on the 
amount of myxoid stroma: classical, cellular, and 
mixed types (8), although  some authors disagree 
with the existing classification (9,10). Histologically, 
the “classic type” presents as a multinodular/multilob-
ular lesion with an abundant myxoid matrix outlined 
by thin condensed fibrous tissue (4). The lesion usu-
ally shows stellate and spindle-shaped cells typically 
grouped in cords, nests, and/or syncytial aggregates, 
randomly scattered in a predominantly edematous 
and myxomatous stroma (4,9). The “cellular type” is 
characterized by spindle and epithelioid cells prolif-
erating in the fibromyxoid stroma, which form lobu-
lar aggregates and sheet-like areas exhibiting a cel-
lular appearance. The cells have round nuclei with 
eosinophilic cytoplasm (4). Histology of the “mixed 
type” frequently shows an aggregate of stellate and 
spindle-shaped cells with basophilic ovoid vesicular 
nuclei scattered mainly in myxoid stroma, which can 
be identified as mucoid using Alcian blue staining 
(4,11).
There are conflicting reports in the literature about 
the expression of S-100 protein in most of the tumor 
cells. A recent analysis of 178 patients with neu-
rothekeoma – including myxoid NTK/NSM – provides 
no evidence of expression of the S-100 protein (9). 
Another study has shown that positive staining 
for S-100 protein was over-expressed in 22 tumors, 
of which 11 were diagnosed as myxoid NTK/NSM and 
expressed S-100 (10). 
Other reported cases have also shown a positive 
S-100 protein antigen immunoprofile in the mixed 
variants of NSM (5,12,-14), although it appears that 
no immunoreactivity for S-100 protein is detectable 
in myxoid NTK/NSM when cells are less differentiated 
(10). Immunohistochemical profiles seem differ in the 
classic and cellular types of NSM. 
The NSM “classic type” displays frequent findings 
of Schwann cells that are immunoreactive for S-100 
protein in the tumor tissues (3,4,7).
Figure 3. The gross specimen showing a round mass, 
1.0 × 0.8 cm in size.
Figure 1. Nerve sheath myxoma of the tongue at ad-
mission.
Figure 2. Intraoperative picture of nerve sheath myx-
oma during the surgical procedure.
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Study Case Gender Age Location Size (cm)
Mincer et al.11 1 M 23 Tongue 1.0
Tomich12 2 M & F NR-45 BM, Tongue NR;NR
Sist et al.13 2 F 30-41 Retromolar, BM 0.5;NR
Wright et al.14 1 F 15 Palate NR
Gallager et al.2 1 ? NR BM NR
Mason et al.15 1 F 32 Lip 1.0x0.7x0.5
Yamamoto et al.16 1 F 41 Tongue 0.8x0.6x0.4
Terrier et al.17 1 M 35 Lip 5x3
Rodriguez-Peralto et al.18 1 F 46 BM 0.8
Smith et al.19 1 F 46 Tongue NR
Tiffee et al.20 1 F 71 Lip-BM 0.9x0.6
Katsourakis et al.21 1 M 24 Lip 2x2x5
Breuer et al.22 1 F 12 Tongue 1.5x2
Pennarocha et al.8 1 F 1 Tongue 3x2.5
Schortinghuis23 1 M 73 Tongue 1.2x0.8x0.7
Barret et al.24 1 M 29 BM 1.5x1.2
Makino et al.9 1 M 8 Tongue 0.8x0.5x0.4
Capodiferro et al.10 1 M 44 Tongue 0.5x0.5
Nishioka et al.4 3 F(2), M 53-2-52 BM (2), Lower lip
4.0x2.0; 0.7x0.8; 
0.7x0.7
Safadi et al.5 1 F 32 Gingiva 0.8x0.6x0.6
Eksi et al.6 1 F 28 Upper lip NR
Green et al28 7 NR NR NR NR
Marocchio et al 29 1 M 35 Palate NR
Prado et al 30 1 F 84 Mandibular lingual gingiva 1.0
Kim et al31 1 F 15 Tongue 2.1
Plaza et al32 1 F 64 NR NR
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The NSM “cellular type” is consistently positive for 
S-100A6 and usually S-100 negative (7,15). Nishioka 
et al. have observed nerve sheath differentiation of 
mixed and cellular types in 3 oral cases of NSM, which 
led the authors to support the theory that different 
types of NSM form a morphologic spectrum rather 
than distinct disease entities (4). Therefore, the dif-
ferent variants of NSM could have the same origin, 
closely related to true nerve sheath tumor (4). Fetsch 
et al. stated that the morphological and immunohis-
tochemical profile of NTK/NSM is distinct from that 
of true NSM. The authors speculated that NTK/NSM 
might be derived from fibroblastic cells with the abil-
ity to differentiate into myofibroblasts and the pro-
Table 1. Clinical characteristics of 41 nerve sheath myxoma (NSM) found in the literature, modified from 
Vered et al.(7). BM, buccal mucosa; NR, not reported.
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pensity to recruit histiocytic cells (9). The differential 
diagnosis of an apparent non-neural NSM includes 
traumatic fibroma, fibro-papilloma, oral focal muci-
nosis, soft tissue myxoma, lipoma, ectomesenchymal 
chondromyxoid tumor, and myxoid malignant fibrous 
histiocytoma. On the other hand, granular cell tumor, 
myxoid neurofibroma, true neuroma, neurilemmoma 
(Schwannoma), and perineurinoma should be con-
sidered in the differential diagnosis of NSM of neural 
origin (5,11,16,17). 
Regarding neural lesions, histological diagnosis of 
NSM overlaps with neurilemmomas, which are rarely 
myxoid in appearance, and contain areas of increased 
cellularity (Antoni A tissue) with the formation of 
Verocay bodies. True encapsulation is seen in nerve 
sheath myxoma (5,11,14), while true neuromas show 
nerve axons organized in fascicles (5,11). 
Myxoid neurofibromas have been infrequently re-
ported in the oral cavity, but the possible association 
of these neoplastic diseases with systemic manifesta-
tions (e.g. Von Recklinghausen’s disease and multiple 
endocrine neoplasia) makes an accurate diagnosis 
very important. 
Myxoid neurofibromas show a positive immuno-
reactivity for S-100 protein, but are not capsulated 
and composed of slender and closely aggregated fas-
cicles of cells placed in loose myxoid stroma (5,11,14). 
Perineurinomas are positive for EMA, whereas S-
100 protein antigen detection is normally negative 
(18,19).
Other non-neural lesions that may be similar to 
NSM and should considered in differential diagnosis 
(within the histological field) are oral focal mucinosis, 
soft tissue myxoma, myxoid malignant fibrous his-
Figure 7. Neurothekeoma with distinctive compart-
mentalized appearance at low power: original mag-
nification ×2.5.
Figure 4. Histopathology of nerve sheath myxoma 
showing a hypocellullar tumor with a multinodular 
pattern and spindle and stellate cells lying within 
stromal mucin (H&E; x200).
Figure 5. Immunohistochemistry of the lesion: Vi-
mentin immunoreactivity in neurothekeoma. Immu-
noperoxidase: original magnification ×200. 
Figure 6. Immunohistochemistry of lesion: S100 im-
munoreactivity in neurothekeoma. Immunoperoxi-
dase: original magnification ×200. 
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tiocytoma, and ectomesenchymal chondromyxoid 
tumor. Oral focal mucinosis is not as circumscribed, 
lobulated, or cellular as NSM and is usually negative 
for S-100 protein (7,14). Oral myxomas are poorly 
marginated compared with NSM, and are typically 
negative for S-100 protein (7,18,19). Myxoid malig-
nant fibrous histiocytoma shows a greater degree of 
nuclear pleomorphism as well as mitotic activity com-
pared with nerve sheath myxoma (11). In contrast to 
NSM, ectomesenchymal chondromyxoid tumor dis-
plays biphasic myxoid and chondroid patterns and is 
positive for both glial fibrillary acidic protein (GFAP) 
and cytokeratin, even if it is infrequently stained with 
antibodies for smooth muscle actin and S-100 pro-
tein (17).
CoNCLuSIoN
Surgical excision is usually the therapy of choice 
for NSM. Recurrence of NSM has not been reported 
after surgery. We emphasize the value of immuno-
histochemistry in the differential diagnosis between 
nerve sheath myxoma and other oral myxomas.
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